Navigation Links
PRA International Participating in Pharmacoeconomics and Outcomes Research Conference
Date:5/15/2009

RALEIGH, N.C., May 15 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces it will exhibit at the annual meeting for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), May 18-20 in Orlando, Florida. Experts from PRA's Late Phase Services group will be present in Booth 19 at ISPOR to discuss PRA's capabilities.

PRA's Late Phase Services group supports global and regional Post-Approval studies. With many years experience managing late phase studies ranging in size from 60 to 18,000 patients in over 40 countries, our international management team leads a truly global late phase team with centralized locations in Horsham, PA and Mannheim, Germany. PRA supports our Late Phase Services operational team with industry-leading strategic, scientific, medical and epidemiological experts.

To coordinate a meeting with PRA at ISPOR or for information on our upcoming audio conference, Blending REMS Science & Operational Execution, please contact David Fineza via email at finezadavid@praintl.com .

About PRA International

PRA International is a global Clinical Research Organization providing services through all phases of clinical development. We perform studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. PRA has supported over 2,100 clinical trials through its 35 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit http://www.prainternational.com, email endpoints@praintl.com or call our Global Headquarters at +1 (919) 786-8200.


'/>"/>
SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix to Exhibit at the BIO 2009 International Convention
2. BioMS Medical to participate in panel session at Bio International Convention 2009
3. Kibow Biotech, Inc. to Present at BIO 2009 International Convention: Innovations to Heal, Fuel, and Feed the World
4. PAREXEL Consulting Experts To Present Insights Into Achieving Regulatory Approval at the 2009 BIO International Convention
5. Cell Therapeutics, Inc. (CTI) to Present at 2009 BIO International Convention
6. Boston Scientific to Donate Cardiac Rhythm Management Devices to Heartbeat International for Implantation in Needy Patients
7. Poniard Pharmaceuticals to Present at the 2009 BIO International Convention
8. BlueFire Ethanol To Present at BIO 2009 International Convention
9. GeoVax to Exhibit at the 2009 BIO International Convention
10. Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance
11. DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017 Infectex Ltd., a Russian portfolio ... 2b-3 clinical study of SQ109 added to the standard drug therapy regimen in patients ... scientists at Sequella, Inc. ( USA ) and the US National Institutes ... ... Maxwell Biotech Venture Fund Logo ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... to engineer scalable and customizable vascular grafts in JoVE’s Video Journal, the world’s ... to new and improved ways of treating coronary artery disease (CAD). Lam is ...
(Date:3/24/2017)... ROCKVILLE, Md. , March 24, 2017 ... Biotech Venture Fund (MBVF), today announced positive results of ... the standard drug therapy regimen in patients with multidrug-resistant ... drug discovered by scientists at Sequella, Inc. ( ... Health. A total of 140 patients ...
(Date:3/24/2017)... Mass. , March 24, 2017 Agenus ... of immune checkpoint antibodies and cancer vaccines, today announced ... The 7 th  Annual William Blair and Maidstone Life ... Space Alexandria Center in New York, NY ... March 29 at 9:40 am: Robert ...
Breaking Biology Technology:
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... Recidivism and Reentry. "Too often, too ... prisons and county jails are trying to tackle ... inmates and friends and family members. While significant steps ...
(Date:2/21/2017)... 21, 2017 Der weltweite Biobanking-Sektor ... Nach einem Gespräch mit mehr als 50 Vertretern aus verschiedenen ... überwinden gilt, um diese Prognose zu realisieren. ... Zu ... der finanziellen Mittel für die Biobank, die Implementierung Zeit ...
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 Commission ... Judiciary Committee, Janice Kephart of Identity Strategy ... Donald Trump,s "Executive Order: Protecting the Nation ... 27, 2017):  "As President Trump,s ,Travel Ban, ... has now essentially banned the travel ban, it is ...
Breaking Biology News(10 mins):